<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The grading of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> has prognostic importance, however observer variation limits the reliability of simple histological analysis alone </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated Ki-67, p53 and Bcl-2 expression in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, in the sequence from Barrett's low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> to high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and infiltrating <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Forty-four esophagectomy specimens were utilized: 39 specimens with <z:mp ids='MP_0000467'>esophageal dysplasia</z:mp> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and 5 specimens with <z:mp ids='MP_0000467'>esophageal dysplasia</z:mp> only </plain></SENT>
<SENT sid="3" pm="."><plain>This gave 83 sections (2 sections for specimens with dyplasia and <z:mp ids='MP_0002038'>carcinoma</z:mp>) examined from 44 patients </plain></SENT>
<SENT sid="4" pm="."><plain>The sections were examined for Ki-67, p53 and Bcl-2 reactivity by immunohistochemistry </plain></SENT>
<SENT sid="5" pm="."><plain>Low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was present in 14 sections, high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in 30 sections and <z:mp ids='MP_0002038'>carcinoma</z:mp> in 39 sections </plain></SENT>
<SENT sid="6" pm="."><plain>Ki-67 expression occurred in 2 out of 14 (14%) sections with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, in 22 out of 30 (73%) sections with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and in 34 out of 39 (87%) sections with <z:mp ids='MP_0002038'>carcinoma</z:mp> (p&lt;0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>p53 protein expression was found in 1 of 14 (7%) sections with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, in 18 of 30 (60%) sections with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and in 33 of 39 (85%) sections with <z:mp ids='MP_0002038'>carcinoma</z:mp> (p&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Expression of Bcl-2 was found in 11 of 14 (84%) sections with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> but immunoreactivity was not seen in any section with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or Barrett's <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Our results indicate that overexpression of Ki-67, Bcl-2 protein and p53 mutations can be identified as early events during <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>These data support the hypothesis that, in the progression of Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, the balance of proliferation/<z:mpath ids='MPATH_3'>apoptosis</z:mpath> plays an important role </plain></SENT>
</text></document>